Metabolic changes in hypertrophic cardiomyopathies: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology

• Type: Article in International Scientific Journal
• Date: 2018

Authors

van der Velden, J (Author) Other; Tocchetti, CG (Author) Other; Varricchi, G (Author) Other; Bianco, A (Author) Other; Sequeira, V (Author) Other; Hilfiker Kleiner, D (Author) Other; Hamdani, N (Author) Other; Leite-Moreira AF (Author) FMUP; Mayr, M (Author) Other; Falcao Pires, I (Author) FMUP; Thum, T (Author) Other; Dawson, DK (Author) Other; Balligand, JL (Author) Other; Heymans, S (Author) Other

Journal

Title: Cardiovascular Research

Vol. 114

Pages: 1273-1280

ISSN: 0008-6363

Publisher: Oxford University Press

Indexing

ISI Web of Knowledge - 54 Citations

Scopus - 60 Citations

Other information

Authenticus ID: P-00P-G1Q

DOI: 10.1093/cvr/cvy147

Abstract (EN): Disturbed metabolism as a consequence of obesity and diabetes may cause cardiac diseases (recently highlighted in the cardiovascular research spotlight issue on metabolic cardiomyopathies). 1 In turn, the metabolism of the heart may also be disturbed in genetic and acquired forms of hypertrophic cardiac disease. Herein, we provide an overview of recent insights on metabolic changes in genetic hypertrophic cardiomyopathy and discuss several therapies, which may be explored to target disturbed metabolism and prevent onset of cardiac hypertrophy.

Language: English

Type (Professor's evaluation): Scientific

No. of pages: 8